May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This source describes New Hair4U Solution as containing Minoxidil, which is known to reduce hair thinning, stimulate inactive follicles, and improve hair density by enhancing scalp circulation and promoting stronger hair growth.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This source highlights the benefits of New Hair4U Solution, containing Minoxidil, which is noted to aid in reducing hair thinning, stimulating inactive hair follicles, supporting scalp circulation, and promoting stronger hair growth and improved density.
7 citations
,
June 2020 in “Journal of The European Academy of Dermatology and Venereology” This article discusses the role of Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants in predicting the response to oral minoxidil for treating female pattern hair loss, without presenting new research findings.
3 citations
,
September 2019 in “PLOS ONE” In this study, the authors identified the DHRS9 SNP rs72623193 as most significantly associated with response to dutasteride in treating male pattern hair loss, with additional variants potentially contributing.
1 citations
,
September 2019 in “Practica medicală” This article discusses the challenges in treating androgenic alopecia and highlights its potential links to coronary heart disease and metabolic syndrome but reports no new clinical findings.